AKTS Aktis Oncology, Inc. - Common stock
$24.77
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026
52W Range
$15–$34
52% of range
Analyst Rating
STRONG BUY
13 analysts
Price Target
$34
+39% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
AKTS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$24.77
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$15 – $34
AKTS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AKTS
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AKTS
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AKTS
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AKTS
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AKTS
Peer Median
AKTS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
13 analysts
- Strong Buy 6 46.2%
- Buy 6 46.2%
- Hold 1 7.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-08-17
Median
$33.50
Mean
$34.42
← Below all targets
$24.77
Low
$31.50
High
$40.00
Median target
$33.50
+35.2%
Mean target
$34.42
+38.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.35%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.38 | $-0.34 | -0.04% |
| Dec. 31, 2025 | $-0.30 | $-1.04 | 0.74% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AKTS | — | — | — | — | — | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 18
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $38M | |
| Prepaid Expense | $4M | |
| Current Assets | $230M | |
| PP&E (Net) | $15M | |
| PP&E (Gross) | $20M | |
| Accum. Depreciation | $6M | |
| Total Assets | $265M | |
| Accounts Payable | $2M | |
| Accrued Liabilities | $10M | |
| Current Liabilities | $31M | |
| Capital Leases | $10M | |
| Total Liabilities | $78M | |
| Common Stock | $0 | |
| Retained Earnings | $-157M | |
| AOCI | $42.0K | |
| Stockholders' Equity | $-146M | |
| Liabilities + Equity | $265M | |
| Shares Outstanding | 915,261 |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $3M | $3M | $2M | $1M | |
| R&D Expense | $25M | $20M | $19M | $16M | |
| SG&A Expense | $7M | $6M | $4M | $4M | |
| Operating Expenses | $32M | $26M | $23M | $20M | |
| Operating Income | $-29M | $-23M | $-21M | $-18M | |
| Interest Income | $5M | $4M | $3M | $3M | |
| Other Non-op | $-10.0K | $-3.0K | $-20.0K | $-13.0K | |
| Net Income | $-24M | $-18M | $-18M | $-15M | |
| EPS (Basic) | $-0.44 | $-0.38 | $-22.39 | $-18.60 | |
| EPS (Diluted) | $-0.44 | $-0.38 | $-22.39 | $-18.60 | |
| Shares (Basic) | 55,300,107 | 48,630,038 | 807,281 | 805,821 | |
| Shares (Diluted) | 55,300,107 | 48,630,038 | 807,281 | 805,821 | |
| EBITDA | $-29M | $-22M | · | · |
Balance Sheet 18
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $82M | $372M | · | · | |
| Prepaid Expense | $7M | $5M | · | · | |
| Current Assets | $525M | $544M | · | · | |
| PP&E (Net) | $16M | $15M | · | · | |
| PP&E (Gross) | $23M | $21M | · | · | |
| Accum. Depreciation | $7M | $6M | · | · | |
| Total Assets | $558M | $577M | · | · | |
| Accounts Payable | $3M | $1M | · | · | |
| Accrued Liabilities | $11M | $6M | · | · | |
| Current Liabilities | $32M | $28M | · | · | |
| Capital Leases | $10M | $10M | · | · | |
| Total Liabilities | $73M | $71M | · | · | |
| Common Stock | $5.0K | $5.0K | · | · | |
| Retained Earnings | $-199M | $-175M | · | · | |
| AOCI | $-745.0K | $-241.0K | · | · | |
| Stockholders' Equity | $485M | $506M | · | · | |
| Liabilities + Equity | $558M | $577M | · | · | |
| Shares Outstanding | 53,446,222 | 53,403,173 | · | · |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $879.0K | $652.0K | $552.0K | $484.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | |
| Other Non-cash | · | $-10M | · | · | |
| Operating Cash Flow | $-21M | $-24M | $-16M | $-17M | |
| CapEx | $1M | $2M | $2M | $2M | |
| Investing Cash Flow | $-269M | $21M | $68M | $39M | |
| Stock Issued | · | $5M | · | · | |
| Net Stock Activity | · | $5M | · | · | |
| Financing Cash Flow | $156.0K | $338M | $0 | $-468.0K | |
| Free Cash Flow | · | $-26M | · | · |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Margin | -854.0% | -703.6% | · | · | |
| Net Margin | -713.5% | -567.9% | · | · | |
| EBITDA Margin | -854.0% | -683.4% | · | · | |
| ROA | -8.7% | -6.3% | · | · | |
| ROE | -10.0% | -7.2% | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 16.3 | 19.5 | · | · | |
| Quick Ratio | 2.6 | 13.3 | · | · |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · |
Valuation (TTM) 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Market Cap | $1.72B | $955M | · | · | |
| P/B | 3.6 | 1.9 | · | · | |
| P / Tangible Book | 3.6 | 1.9 | · | · | |
| P / Cash Flow | · | -39.4 | · | · | |
| P / FCF | · | -36.6 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 114 filers · $903.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 57 | 6 | 25 | 14 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | $155,860,155 | 4,835,872 | 17.25% | Shares |
| EcoR1 Capital, LLC | $155,492,636 | 4,824,469 | 17.21% | Shares |
| Blue Owl Capital Holdings LP | $98,953,158 | 3,070,219 | 10.95% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $62,956,277 | 1,953,344 | 6.97% | Shares |
| RTW INVESTMENTS, LP | $51,311,546 | 1,592,043 | 5.68% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $42,363,273 | 1,314,405 | 4.69% | Shares |
| BAKER BROS. ADVISORS LP | $32,112,393 | 996,351 | 3.55% | Shares |
| Octagon Capital Advisors LP | $30,968,099 | 960,847 | 3.43% | Shares |
| Merck & Co., Inc. | $30,710,162 | 952,844 | 3.40% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $26,334,327 | 817,075 | 2.91% | Shares |
| JANUS HENDERSON GROUP PLC | $26,022,437 | 1,454,267 | 2.88% | Shares |
| TCG Crossover Management, LLC | $22,450,129 | 696,560 | 2.48% | Shares |
| EVENTIDE ASSET MANAGEMENT, LLC | $16,340,610 | 507,000 | 1.81% | Shares |
| Avidity Partners Management LP | $15,605,766 | 484,200 | 1.73% | Shares |
| STATE STREET CORP | $15,599,642 | 484,010 | 1.73% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $14,431,723 | 447,645 | 1.60% | Shares |
| a16z Capital Management, L.L.C. | $13,375,450 | 415,000 | 1.48% | Shares |
| Alyeska Investment Group, L.P. | $9,346,700 | 290,000 | 1.03% | Shares |
| FMR LLC | $9,205,887 | 285,631 | 1.02% | Shares |
| ArrowMark Colorado Holdings LLC | $7,924,455 | 245,872 | 0.88% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5,377,318 | 166,842 | 0.60% | Shares |
| BARCLAYS PLC | $4,841,688 | 150,223 | 0.54% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4,680,441 | 145,220 | 0.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $4,313,470 | 133,834 | 0.48% | Shares |
| TD Asset Management Inc | $3,413,221 | 105,902 | 0.38% | Shares |
| SOROS FUND MANAGEMENT LLC | $3,223,000 | 100,000 | 0.36% | Shares |
| Woodline Partners LP | $3,223,000 | 100,000 | 0.36% | Shares |
| UBS Group AG | $3,183,035 | 98,760 | 0.35% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $3,074,742 | 95,400 | 0.34% | Shares |
| BlackRock, Inc. | $2,517,582 | 78,113 | 0.28% | Shares |
| POLEN CAPITAL MANAGEMENT LLC | $2,047,056 | 63,514 | 0.23% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1,548,458 | 48,044 | 0.17% | Shares |
| RAYMOND JAMES FINANCIAL INC | $1,534,954 | 47,625 | 0.17% | Shares |
| Quantinno Capital Management LP | $1,511,168 | 46,887 | 0.17% | Shares |
| GREAT LAKES ADVISORS, LLC | $1,405,615 | 43,612 | 0.16% | Shares |
| Mirador Capital Partners LP | $1,293,197 | 40,124 | 0.14% | Shares |
| Squarepoint Ops LLC | $1,237,020 | 38,381 | 0.14% | Shares |
| Jump Financial, LLC | $1,056,467 | 32,779 | 0.12% | Shares |
| Sofinnova Investments, Inc. | $1,045,412 | 32,436 | 0.12% | Shares |
| TWO SIGMA INVESTMENTS, LP | $996,358 | 30,914 | 0.11% | Shares |
| READYSTATE ASSET MANAGEMENT LP | $966,900 | 30,000 | 0.11% | Shares |
| RHUMBLINE ADVISERS | $868,429 | 26,945 | 0.10% | Shares |
| CITADEL ADVISORS LLC | $823,058 | 25,537 | 0.09% | Shares |
| SEVEN GRAND MANAGERS, LLC | $805,750 | 25,000 | 0.09% | Shares |
| Ghisallo Capital Management LLC | $805,750 | 25,000 | 0.09% | Shares |
| TUDOR INVESTMENT CORP ET AL | $689,786 | 21,402 | 0.08% | Shares |
| GOLDMAN SACHS GROUP INC | $685,790 | 21,278 | 0.08% | Shares |
| AMERIPRISE FINANCIAL INC | $644,600 | 20,000 | 0.07% | Shares |
| BANK OF AMERICA CORP /DE/ | $626,648 | 19,443 | 0.07% | Shares |
| Mariner, LLC | $572,697 | 17,770 | 0.06% | Shares |
| Virtus Investment Advisers, LLC | $480,872 | 14,920 | 0.05% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $463,435 | 14,379 | 0.05% | Shares |
| Bank of New York Mellon Corp | $438,618 | 13,609 | 0.05% | Shares |
| MetLife Investment Management, LLC | $418,797 | 12,994 | 0.05% | Shares |
| CITIGROUP INC | $385,245 | 11,953 | 0.04% | Shares |
| Caprock Group, LLC | $319,335 | 9,908 | 0.04% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $314,855 | 9,769 | 0.03% | Shares |
| WELLS FARGO & COMPANY/MN | $281,465 | 8,733 | 0.03% | Shares |
| Invesco Ltd. | $280,949 | 8,717 | 0.03% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $277,919 | 8,623 | 0.03% | Shares |
| JPMORGAN CHASE & CO | $264,787 | 8,794 | 0.03% | Shares |
| Russell Investments Group, Ltd. | $249,911 | 7,754 | 0.03% | Shares |
| SEI INVESTMENTS CO | $247,945 | 7,693 | 0.03% | Shares |
| Nuveen, LLC | $247,945 | 7,693 | 0.03% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $241,725 | 7,500 | 0.03% | Shares |
| MORGAN STANLEY | $234,860 | 7,287 | 0.03% | Shares |
| AXQ CAPITAL, LP | $226,255 | 7,020 | 0.03% | Shares |
| Vanguard Global Advisers, LLC | $221,936 | 6,886 | 0.02% | Shares |
| PNC Financial Services Group, Inc. | $190,157 | 5,900 | 0.02% | Shares |
| Police & Firemen's Retirement System of New Jersey | $178,232 | 5,530 | 0.02% | Shares |
| LANARK FINANCIAL, INC. | $172,688 | 5,358 | 0.02% | Shares |
| NORTHERN TRUST CORP | $107,423 | 3,333 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $105,714 | 3,280 | 0.01% | Shares |
| STRS OHIO | $99,913 | 3,100 | 0.01% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $95,981 | 2,978 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $73,098 | 2,268 | 0.01% | Shares |
| Pinnacle Wealth Planning Services, Inc. | $73,065 | 2,267 | 0.01% | Shares |
| Legal & General Group Plc | $66,623 | 2,062 | 0.01% | Shares |
| T. Rowe Price Investment Management, Inc. | $66,119 | 2,051,447 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $62,043 | 1,925 | 0.01% | Shares |
| SALEM INVESTMENT COUNSELORS INC | $32,230 | 1,000 | 0.00% | Shares |
| State of Wyoming | $31,747 | 985 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $23,439 | 727,235 | 0.00% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $22,589 | 700 | 0.00% | Shares |
| FIFTH THIRD BANCORP | $18,576 | 576 | 0.00% | Shares |
| Rockefeller Capital Management L.P. | $12,795 | 397 | 0.00% | Shares |
| Global Retirement Partners, LLC | $12,731 | 395 | 0.00% | Shares |
| Arax Advisory Partners | $12,408 | 385 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $9,991 | 310 | 0.00% | Shares |
| DEUTSCHE BANK AG\ | $9,927 | 308 | 0.00% | Shares |
| Federation des caisses Desjardins du Quebec | $8,057 | 250 | 0.00% | Shares |
| Sterling Capital Management LLC | $5,930 | 184 | 0.00% | Shares |
| Allworth Financial LP | $3,997 | 124 | 0.00% | Shares |
| IFP Advisors, Inc | $3,255 | 101 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $2,414 | 77 | 0.00% | Shares |
| HM PAYSON & CO | $2,386 | 74 | 0.00% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,030 | 63 | 0.00% | Shares |
| ROTHSCHILD INVESTMENT LLC | $1,257 | 39 | 0.00% | Shares |
| Quarry LP | $1,096 | 34 | 0.00% | Shares |
| SJS Investment Consulting Inc. | $1,064 | 33 | 0.00% | Shares |
Company insiders 6 insiders · 2 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Shulamit Ron-Bigger | Chief Operating Officer | July 8, 2026 M | 0 | 0 | 3 | $-1,387,604 |
| Akos Czibere | Chief Medical Officer | July 8, 2026 M | 0 | 0 | 3 | $-1,388,686 |
| Ken Herrmann | Director | July 20, 2026 M | 0 | 0 | 3 | $-196,532 |
| Glenn Gormley | Director | April 15, 2026 A | — | 0 | 0 | $0 |
| Lloyd Mitchell Segal | Director | Jan. 12, 2026 C | 19,631 | 0 | 0 | $0 |
| Helen Kim | Director | Jan. 12, 2026 C | 157,387 | 2 | 0 | $15,030,000 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| MPM BIOVENTURES 2018, L.P., MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2018 GP LLC, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM BioVentures 2018 LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC, Oncology Impact Private Investment Fund 2, L.P., MPM Oncology Investments 2 LLC, MPM ASSET MANAGEMENT LLC, ANSBERT GADICKE, LUKE EVNIN, Todd Foley | Jan. 20, 2026 | 19.30% | Initial filing | Passive investment | SEC |
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. | Jan. 20, 2026 | 9.10% | Initial filing | Passive investment | SEC |
| Eli Lilly and Company | Jan. 15, 2026 | 11.90% | Initial filing | Passive investment | SEC |
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II LLC, Helen Kim | Jan. 14, 2026 | 10.90% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 20 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 15,659 SH | Aug. 8, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 3,279 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 133,845 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 122,067 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 539,693 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 8,895 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 968 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 213,673 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 5,760 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.01% | 59,227 SH | Aug. 8, 2026 | Daily |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 88,457 NS | May 31, 2026 | N-PORT |
| ISCB · iShares Trust | 0.01% | 904 SH | Aug. 8, 2026 | Daily |
| UWM · ProShares Trust | 0.01% | 757 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 769 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 19 NS | May 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 9,477 SH | Aug. 8, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 34,286 SH | Aug. 8, 2026 | Daily |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 13,916 NS | May 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 585,135 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,734 SH | Aug. 8, 2026 | Daily |